学术探索
学术期刊
文章热点
数据分析
智能智评

肝型脂肪酸结合蛋白(L-FABP)与肾脏疾病

被引：3
作者：
孔祥雷
许冬梅
机构：
[1] 山东大学医学院附属山东省千佛山医院肾内科
来源：
国际泌尿系统杂志 | 2008年 / 04期
关键词：
肾疾病; 载体蛋白质类;
D O I：
暂无
中图分类号：
R692 [肾疾病];
学科分类号：
摘要：
脂肪酸结合蛋白(FABPs)属于脂结合蛋白(lipid-binding proteins)超家族中的一类,根据其组织的特异性分布,可分为肝型(L-FABP)、小肠型(I-FABP)、心肌型(H-FABP)等9种。目前国外研究L-FABP在肾脏疾病中具有重要的意义,国内尚无报道,本文就L-FABP在肾脏疾病中的研究进展做一简要综述。
引用
收藏
页码：517 / 520
相关论文
共 10 条
  • [1] Azelnidipine reduces urinary protein excretion and urinary liver-type fatty acid binding protein in patients with hypertensive chronic kidney disease
    Nakamura, Tsukasa
    Sugaya, Takeshi
    Kawagoe, Yasuhiro
    Suzuki, Tsukasa
    Ueda, Yoshihiko
    Koide, Hikaru
    Inoue, Teruo
    Node, Koichi
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2007, 333 (06) : 321 - 326
  • [2] Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria
    Nakamura, Tsukasa
    Sugaya, Takeshi
    Kawagoe, Yasuhiro
    Ueda, Yoshihiko
    Koide, Hikaru
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (05) : 385 - 389
  • [3] Urinary fatty acid binding protein in renal disease[J] . Atsuko Kamijo-Ikemori,Takeshi Sugaya,Kenjiro Kimura.Clinica Chimica Acta . 2006 (1)
  • [4] Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction
    Kamijo-Ikemori, Atsuko
    Sugaya, Takeshi
    Obama, Ayako
    Hiroi, Junya
    Miura, Hiroshi
    Watanabe, Minoru
    Kumai, Toshio
    Ohtani-Kaneko, Ritsuko
    Hirata, Kazuaki
    Kimura, Kenjiro
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (04) : 1107 - 1117
  • [5] Urinary Excretion of Liver-Type Fatty Acid–Binding Protein in Contrast Medium–Induced Nephropathy[J] . Tsukasa Nakamura,Takeshi Sugaya,Koichi Node,Yoshihiko Ueda,Hikaru Koide.American Journal of Kidney Diseases . 2006 (3)
  • [6] Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease
    Nakamura, T
    Sugaya, T
    Kawagoe, Y
    Ueda, Y
    Osada, S
    Koide, H
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 330 (04) : 161 - 165
  • [7] Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: A multicenter trial[J] . Atsuko Kamijo,Takeshi Sugaya,Akihisa Hikawa,Masaya Yamanouchi,Yasunobu Hirata,Toshihiko Ishimitsu,Atsushi Numabe,Masao Takagi,Hiroshi Hayakawa,Fumiko Tabei,Tokuichiro Sugimoto,Naofumi Mise,Kenjiro Kimura.The Journal of Laboratory and Clinical Medicine . 2005 (3)
  • [8] Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal disease[J] . Atsuko Kamijo,Kenjiro Kimura,Takeshi Sugaya,Masaya Yamanouchi,Akihisa Hikawa,Norihito Hirano,Yasunobu Hirata,Atsuo Goto,Masao Omata.The Journal of Laboratory and Clinical Medicine . 2004 (1)
  • [9] Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules
    Kamijo, A
    Sugaya, T
    Hikawa, S
    Okada, M
    Okumura, F
    Yamanouchi, M
    Honda, A
    Okabe, M
    Fujino, T
    Hirata, Y
    Omata, M
    Kaneko, R
    Fujii, H
    Fukamizu, A
    Kimura, K
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04) : 1243 - 1255
  • [10] Structural and functional features of different types of cytoplasmic fatty acid-binding proteins .2 J. H. Veerkamp R. A. Peeters and R. G. H. J. Maatman. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism . 1991
1